Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan Yoon Cheah

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|April 18, 2019
Designing optimal prognostic models for diffuse large B-cell lymphomaColm Keane, Chan Yoon Cheah
Oncology (Williston Park, N.Y.)|October 17, 2015
Chemotherapy-Free Treatment of Follicular Lymphoma: We Have the Ingredients, Now for Some RecipesChan Yoon Cheah, Nathan H Fowler
Current Oncology Reports|April 28, 2015
Central nervous system prophylaxis in non-Hodgkin lymphoma: who, what, and when?Chan Yoon Cheah, John F Seymour
Expert Review of Hematology|October 24, 2022
About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?Katharine Louise Lewis, Chan Yoon Cheah
Leukemia & Lymphoma|November 4, 2022
Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?Ross Thomas Salvaris, Chan Yoon Cheah
Blood|June 15, 2017
How I treat patients with aggressive lymphoma at high risk of CNS relapseCollin K Chin, Chan Yoon Cheah
Expert Opinion on Pharmacotherapy|September 4, 2025
Recent advances and future directions in newly diagnosed mantle cell lymphomaWan Danial Noor, Chan Yoon Cheah
Leukemia & Lymphoma|February 26, 2013
Refining the predictors of risk for central nervous system involvement in patients with mantle cell lymphomaChan Yoon Cheah, John F Seymour
Blood|June 3, 2016
Idelalisib in the management of lymphomaChan Yoon Cheah, Nathan H Fowler
Leukemia & Lymphoma|April 4, 2017
Three different hematologists, three different answers: how should we treat concurrent systemic and central nervous system lymphoma?Allison A Barraclough, Chan Yoon Cheah
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|April 18, 2019
Designing optimal prognostic models for diffuse large B-cell lymphomaColm Keane, Chan Yoon Cheah
Oncology (Williston Park, N.Y.)|October 17, 2015
Chemotherapy-Free Treatment of Follicular Lymphoma: We Have the Ingredients, Now for Some RecipesChan Yoon Cheah, Nathan H Fowler
Current Oncology Reports|April 28, 2015
Central nervous system prophylaxis in non-Hodgkin lymphoma: who, what, and when?Chan Yoon Cheah, John F Seymour
Expert Review of Hematology|October 24, 2022
About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?Katharine Louise Lewis, Chan Yoon Cheah
Leukemia & Lymphoma|November 4, 2022
Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?Ross Thomas Salvaris, Chan Yoon Cheah
Blood|June 15, 2017
How I treat patients with aggressive lymphoma at high risk of CNS relapseCollin K Chin, Chan Yoon Cheah
Expert Opinion on Pharmacotherapy|September 4, 2025
Recent advances and future directions in newly diagnosed mantle cell lymphomaWan Danial Noor, Chan Yoon Cheah
Leukemia & Lymphoma|February 26, 2013
Refining the predictors of risk for central nervous system involvement in patients with mantle cell lymphomaChan Yoon Cheah, John F Seymour
Blood|June 3, 2016
Idelalisib in the management of lymphomaChan Yoon Cheah, Nathan H Fowler
Leukemia & Lymphoma|April 4, 2017
Three different hematologists, three different answers: how should we treat concurrent systemic and central nervous system lymphoma?Allison A Barraclough, Chan Yoon Cheah
Pageof 7